North China Pharmaceutical Company.Ltd Sustainability Profile
North China Pharmaceutical Company Ltd. (NCPC), headquartered in China, is a leading player in the pharmaceutical industry, renowned for its extensive range of high-quality products and services. Established in 1999, NCPC has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms, and biopharmaceuticals, catering to both domestic and international markets. With a strong operational presence across various regions in China, NCPC has positioned itself as a key supplier in the healthcare sector. The company is distinguished by its commitment to innovation and quality, offering unique formulations that meet stringent regulatory standards. Notable achievements include its robust portfolio of over 200 products and a reputation for excellence in research and development, solidifying its status as a trusted partner in the global pharmaceutical landscape.
DitchCarbon Score
How does North China Pharmaceutical Company.Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
North China Pharmaceutical Company.Ltd's score of 22 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
North China Pharmaceutical Company.Ltd's reported carbon emissions
North China Pharmaceutical Company Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, North China Pharmaceutical Company Ltd has not inherited any emissions data from a parent or related organization, nor does it participate in any industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific commitments or data, it is unclear how North China Pharmaceutical Company Ltd aligns with these industry trends.
How Carbon Intensive is North China Pharmaceutical Company.Ltd's Industry?
How Carbon Intensive is North China Pharmaceutical Company.Ltd's Location?
North China Pharmaceutical Company.Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
North China Pharmaceutical Company.Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
